Tag

warningletter

Software Warning Letters

Failure to ensure that all inspection, measuring, and test equipment, including mechanical, automated, or electronic inspection and test equipment, is suitable for its intended purposes and is capable of producing valid results, as required by 21 CFR 820.72(a). For example, the _____ used to ____ in _____, has not been validated, to assure it is...
Read More
Thoratec Laboratories 3/10/00″..4. .The implementation of corrective and preventative action (CAPA) procedures at your firm is incomplete in that your procedures do not include reference to the Access electronic database. This database captures information from sources such as complaints and nonconformance reports for use during management reviews. In addition, battery assembly defects, such as loose...
Read More
Individual Monitoring Systems -Electroencephalogry 2/11/00 “…Failure to validate computer software for its intended use. For example, your firm has not validated the software used to perform sensitivity calibration of the ActiTrac device. “ SoftwareCPR keywords: production software validation.
Read More
http://www.fda.gov/foi/warning_letters/m3401n.pdf
Read More
Compnay: SOL PharmaceuticalsProduct: Active pharmaceutical ingredients Poduct Category: Human Drugs Date: 1/21/200 In addition, our investigative team found it impossible to trace computer generated …because they were not date stamped.
Read More
Diasorin, Saluggia Italy 23-Dec-99 production/QC software validation for reagents”8. Failure to ensure that all equipment used in the manufacturing process meets specified requirements and is appropriately designed, constructed, placed, and installed to facilitate maintenance, adjustment, cleaning, and use [21 CFR 820.70(g)] in that the Gamma Counter Data Transfer Validation, dated March 31. 1999. did not...
Read More
7. Failure to maintain complete and adequate written SOPS that reflect current bloodbank operations as requiredby21 CFR 606.100(b) and 606.60. For example, with respect to the computer system in use, there were no SOPS available for security procedures for unauthorized access, review of the system and correction of errors, and control of changes in hardware...
Read More
3d) Standard operating procedure Routine Release of Crossmatched Blood and Blood Products has not been updated to include computter operations utilizing xxx Blood Bank and Blood Donor Computer System versionyyyy. Specifically, the procedure does not include what type of second verification of information entered into the computer should be performed when blood products are released...
Read More
Failure to validate the EtO sterilization process for ATI plasma exchange tubing setsand off-the-shelf software for compiling clinical trial data. Also there are no procedures established and maintained for monitoring and controlling the process parameters for the ATI plasma exchange tubing sets to ensure that specified requirements are met as required by 21 CFR 820.75....
Read More
Mountain View Blood Bank 10/5/99 The _____ Procedure, Revision Date 10-26-94, required donors who test repeatedly reactive for HTLV- 1/2, HIV, HBsAg and HCV to be permanent y deferred and the donors notified. Employees lacked adequate training because they were not following this procedure [21 CFR 606.20(b)]. The donor deferral files were not adequate to...
Read More
Failure to review and evaluate all complaints and maintain a record of the reason no investigation was made and the name of the individual responsible for the decision not to investigate; failure to maintain records that demonstrate that each batch, lot, or unit of device meets in-process or finished device specifications; failure to validate and...
Read More
6. Failure of the DMR (device master record) to include device specifications including appropriate drawings, composition, formulation, component specifications and software specifications, as required by 21 CFR 820.181(a). For example:
Read More
CRS-USA LASIK 8/18/99 Clinical Trial Software Validation There was no verification that the data submitted by the clinical investigators matched source data at the site. The only data verification was performed by the computer data service, xxxx and involved scrutinizing the data for such errors as out-of-range data, field entry omissions, exam dates out-of-range, and...
Read More
South Florida Blood Bank 8/12/99 The inspection revealed that complete and accurate donor deferral records are not being maintained. A deferred donor that tested repeatedly reactive HBsAg on February 12, 1998 (Unit #2251435) was improperly re-entered for donation on August 12, 1998 without a neutralization test being performed. This donor should have remained in deferral....
Read More
Drager Medizintechnik GmbH, 6-Aug-99, Intensive care ventilators, anesthesia and incubators 1. Failure to validate computer software used as part of the quality system for its intended use according to an established protocol as required by 21 CFR 820.70(i). For example, the data in the Excel spreadsheet identified as a “Hit List” of top nonconforming components...
Read More
Vitalograph Ltd., 6-Aug-99, Spirometers and peak flow meters 4. Failure to establish and maintain process control procedures for the monitoring and control of process parameters during production, as required by 21 CFR 820.70(a) and (b). For example, the firm failed to measure the temperature of the wave-soldering machine at the start of every PCB Kit...
Read More
Linweld 8/2/99 Significant deviations include, but may not be limited to the following: Failure to maintain a computer system with validated program capabilities for operating a medical gas facility [21 CFR 1-11.68]. Examples include: No testing of the system after installation at the operating site. Operating sites are part of the overall system and lack...
Read More
Company: Gensia Sicor Pharmaceuticals Inc.Date: 7/21/99 Product: Drug Products Failure to maintain laboratory records to include complete data derived from all tests necessary to assure compliance with established specifications and standards [21 CFR 211.194]. Specifically, your firm failed to properly maintain electronic files containing data secured in the course of tests from 20 HPLCs and...
Read More
Novartis 7/1/99 b. The annual product reviews did not include all stability results. A problem in the firm’s computer system prevented the results of stability data from printing. Additionally, the stability data from these annual reviews was used to support the Tegretol XR expiration date extension. SoftwareCPR keywords: drugs, pharmaceuticals, computer validation
Read More
Prucka 30-June-99 Multi-channel electrocardiographic amplifiers, CardioLab EP System and CardioCath Catheterization Lab System software 2. Failure to establish and maintain procedures for validation of the device design, including software validation, and documentation of the validation, as required by 21 CFR 820.30(g). For example: a. Standard operating procedures have not been established for software validation. b....
Read More
Solvay Pharmaceuticals 6/23/99 Computer System Validation 1. The xxxx computer system, used to monitor and maintain such critical systems as the xxxx and xxxx systems, has not been validated. Our inspection revealed that the xxxx computer system is used to monitor temperature, conductivity, water pressure and time (in hours) for replacement of xxxx for the...
Read More
14. Failure to validate the software programs, Shimadzu and _____ that are used to run the laboratory HPLC equipment, during analysis of raw materials and finished products. The _____ software does not secure data from alterations, losses, or erasures. The software allows for overwriting of original data. There are no written procedures for the use...
Read More
Picker 7-May-99 MRI equipment The following, deviations from the Device Quality System Regulations were documented: 1) Failure to maintain a design file necessary to demonstrate that the design was developed in accordance with the approved design plan as required by 21 CFR 820.30(j). For example, there is no documentation of any module testing of the...
Read More
Failure to investigate the cause of nonconformities relating to product, processes and the quality system; failure to develop, conduct, control and monitor production processes to ensure that a device conforms to its specifications; failure to establish and maintain procedures to prevent contamination of equipment or product by substances that could reasonably be expected to have...
Read More
Incomplete records for all blood components produced; failure to routinely review error messages on computer system. The inspection also revealed that _____ error messages on your computer system are not routinely reviewed, processed, and investigated to determine final disposition. The instructions for computer system training do not include a clear written explanation of what error...
Read More
With regard to FDA-483 Item 4, Braun was cited for not reporting two MDR reportable complaints, Mfr reports #1641965-1998-00018/24, to FDA within the 30 days time frame. Your response indicated that Braun is currently changing the complaint handling system from tracking complaint information on an _____ spreadsheet to using an off-the-shelf database system, _____ tracker....
Read More
B) Failure to validate the computer system controlling the air separation process.
Read More
Failure to exercise appropriate controls over computer or related systems to ensure that changes in records are instituted only by authorized personnel; failure to concurrently maintain a record from which unsuitable donors may be identified; and failure to maintain and/or follow standard written operating procedures to include all steps to be followed in the collection,...
Read More
GE 9-April-99 Solar Model 7000/8000 Patient MonitorsJohn Welch, Jr. Chief Executive Officer General Electric Company 3135 Easton Turnpike Fairfield, Connecticut 06431 Dear Mr. Welch: We are writing to you because on March 8-12, 1999, investigators from the Food and Drug Administration (FDA) collected information from your Marquette Medical Systems, Milwaukee, WI, facility that revealed a...
Read More
The Center for Devices and Radiological Health (CDRH), Office of Compliance, Division of Enforcement I, Diagnostic Devices Branch has reviewed the January/February 1999 Establishment Inspection Report of your firm, and the Form FDA 483 dated February 5, 1991, that was issued to you at the close of the FDA inspection. They also reviewed your product...
Read More
Radionics 22-March-99 Xknife Stereotactic Radiosurgery System 1. Failure to establish and maintain procedures to ensure that formal documented reviews of the design results are planned and conducted at appropriate stages of the device’s design development, that appropriate representatives are included, and that the results of a design review, including identification of the design, the date,...
Read More
Abbott 17-March-99 In vitro diagnostic products 2. Failure to document all activities required by 21 CFR 820.100(b) as they relate to corrective and preventive action. For example: a. There is no documentation of the management review and approval of the decision not to send a customer communication to alert Axsym instrument users of a system...
Read More
Baxter 3/12/99 Catheters 2. Failure to validate production processes with a high degree of assurance where the results of a process cannot be fully verified by subsequent inspection and test [21CFR 820.75). Specifically, your firm does not have sufficient documented evidence, that the Pulmonary Artery Catheter balloon forming, and the polyethylene (PVC)compounding processes meet their...
Read More
In response to your inquiry concerning the need to maintain manual discard records when the same date is computerized, I can assure you that duplicative, manual records are not required, PROVIDED your computer system(s) are validated to ensure that all necessary data is entered, that the stored data is safely backed-up in the event of...
Read More
Medical Equipment Designs 9-March-99 Diathermy devices Since 1990, you also modified the design of the Meditherm by introducing software to control the device. Major changes in the intended use of the Meditherm and design changes which could significantly affect safety or effectiveness, such as the introduction of software, require a new premarket notification (510(k)) submission...
Read More
Urometrics 9-March-99 Penile tumescence monitors 1. Failure to establish and maintain procedures for the identification, documentation, validation, or appropriate verification, review and approval of design changes before their implementation as required by 21 CFR 820.30(i) in that there is no data to show that the NEVA program version 2.2.1 (revised 1/20/99) was validated or verified....
Read More
Chronimed 3/2/99 Glucose test strips and meters 5. Failure to establish and maintain plans that describe or reference the design and development activities and define responsibility for implementation as required by 21 CFR 820.30(b). For example, there is no plan for the software validation for Version 104. 6. Failure to ensure that the design input...
Read More
Compex S.A. 2/22/99 Muscle and nerve stimulation devices 2. Failure to validate computer software for its intended use according to an established protocol, when computers or automated data processing systems are used as part of production or the quality system, as required by 21 CFR 820.70(i). For example, your firm failed to validate the software...
Read More
Diehl Inc. Food Processing 2/12/99 The chart recorder and the computer display on the xxxx units did not correspond to the mercury-in-glass (MIG) thermometer. The chart recorder or computer display may show a reading up to 3 degrees F higher than the MIG thermometer. SoftwareCPR keywords: Production software, validation, electronic records
Read More
Inadequate process validation; failure to validate the test methods used to analyze raw materials and the finished product; failure to institute process qualification for the laboratory instruments used to perform in-process and finished product testing; failure to qualify or validate the firm’s computer software programs; and failure to perform investigations into out-of-specification weight and diameter...
Read More
Knoll Pharmaceutical 12/14/98 Your firm’s equipment qualifications for the Amsco SG-116 autoclave and the computer control system for the 60″ film coating pan were inadequate. SoftwareCPR keywords: software validation, CDER, Drugs, Pharma
Read More
Soft Computer Consultants 12/4/98 Blood Bank Computer SoftwareDESIGN CONTROLS 1) Failure to establish and maintain plans that describe or reference the design and development activities, and define responsibility for implementation including the plans that describe the interfaces with different groups that provide input to the design and development process [21 CFR 820.30(b)]. 2) Failure to...
Read More
Ultramedic Ltd. 11/25/98 Infusion Pump Analyzers 6. Failure to have an established protocol to validate computer software for its intended use when computers or automated data processing systems are used as part of production or the quality system, as required by 21 CFR 820.70(i). For example, there is no validation protocol for the validation study...
Read More
North American Science Assoc 11/24/98 Contract Testing Laboratory Failure to maintain adequate controls over computers and related systems to assure that changes in the master production and control records or other records are instituted only by authorized personnel [21 CFR 211.68(b)]. For example: (1) there is no current listing of individuals who have access to...
Read More
North American Science Contract Test Laboratory 11/24/98 Failure to maintain adequate controls over computers and related systems to assure that changes in the master production and control records or other records are instituted only by authorized personnel [21 CFR 211.68(b)]. For example: (1) there is no current listing of individuals who have access to the...
Read More
Allergy Laboratories 8/14/98 8. There are no controls for computer generated labeling used for product inserts. It was noted during the inspection that finished HealthTest HIV 1 + 2 and HBsAg test kits were relabeled from “For in vitro use only” to “For Research Use Only”. SoftwareCPR keywords: software validation, CDRH, devices
Read More
Villa Sistemi Medicali, S.p.A. 9/30/98 Dental x-ray systems Failure to maintain Device Master Records (DMR) that includes or refers to the location of: device specifications including component specifications, software specifications; production process specifications; quality assurance procedures; and labeling specifications as required by 21 CFR 820.181(a)(b)(c) and (d). For example, the firm has no Device Master...
Read More
ICS Medical 10/29/98 Diagnostic opthalmic devices 1. Failure to develop, monitor, and control the software development processes to ensure that the software used in _____ conforms to its original design or any approved changes. 2. Failure to review the software development process to identify actions needed to prevent the recurrence of software nonconformances. 3. Failure...
Read More
Review of the _____ which consisted of the software and hardware components necessary to _____ DHRs and maintain them as electronic records, revealed the following:. Changes to processes were not always reviewed and evaluated or revalidated, where appropriate, and documented [21 CFR 820.75(c)], in that the software validation dated _____ was completed for software _____...
Read More
1 5 6 7 8 9

SoftwareCPR Training Courses:

IEC 62304 and other emerging standards for Medical Device and HealthIT Software

Our flagship course for preparing regulatory, quality, engineering, operations, and others for the activities and documentation expected for IEC 62304 conformance and for FDA expectations. The goal is to educate on the intent and purpose so that the participants are able to make informed decisions in the future.  Focus is not simply what the standard says, but what is meant and discuss examples and approaches one might implement to comply.  Special deep discount pricing available to FDA attendees and other regulators.

3-days onsite with group exercises, quizzes, examples, Q&A.

Instructor: Brian Pate

Next public offering:  TBD

Email training@softwarecpr.com to request a special pre-registration discount.  Limited number of pre-registration coupons.

Registration Link:

TBD

 


 

Being Agile & Yet Compliant (Public or Private)

Our SoftwareCPR unique approach to incorporating agile and lean engineering to your medical device software process training course is now open for scheduling!

  • Agile principles that align well with medical
  • Backlog management
  • Agile risk management
  • Incremental and iterative software development lifecycle management
  •  Frequent release management
  • And more!

2-days onsite (4 days virtual) with group exercises, quizzes, examples, Q&A.

Instructors: Mike Russell, Ron Baerg

Next public offering: March 7 & 28, 2024

Virtual via Zoom

Registration Link:

Register Now

 


 

Medical Device Cybersecurity (Public or Private)

This course takes a deep dive into the US FDA expectations for cybersecurity activities in the product development process with central focus on the cybersecurity risk analysis process. Overall approach will be tied to relevant standards and FDA guidance documentation. The course will follow the ISO 14971:2019 framework for overall structure but utilize IEC 62304, IEC 81001-5-1, and AAMI TIR57 for specific details regarding cybersecurity planning, risk characterization, threat modeling, and control strategies.

2-days onsite with group exercises, quizzes, examples, Q&A.

Instructor: Dr Peter Rech, 2nd instructor (optional)

Next public offering:  TBD

Corporate Office

15148 Springview St.
Tampa, FL 33624
USA
+1-781-721-2921
Partners located in the US (CA, FL, MA, MN, TX) and Canada.